The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
270 jobs Number of planned job losses
Announcement Date
14 June 2016
Employment effect (start)
1 August 2016
Foreseen end date
31 January 2017
Description
Pharmaceutical and biotechnology company Baxter Poland has announced that it will close down its facility in Lublin and cut all 270 jobs by the end of January 2017. The restructuring programme will be launched in August 2016. The production will be phased out until a complete closure of the factory in January 2017. Most of the production lines will be relocated to other company's sites.
Baxter Poland is a subsidiary of the American company Baxter International which operates in 110 countries and employs almost 50,000 people worldwide. The company has been operating in Lublin since 2007; the unit produces medical products.
Sources
14 June 2016: Gazeta Wyborcza
Citation
Eurofound (2016), Baxter Poland, Closure in Poland, factsheet number 88170, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/88170.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
